See more : Excellon Resources Inc. (EXN) Income Statement Analysis – Financial Results
Complete financial analysis of InterCure Ltd. (INCR.TA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of InterCure Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Kawasaki Geological Engineering Co., Ltd. (4673.T) Income Statement Analysis – Financial Results
- Coles Group Limited (COL.AX) Income Statement Analysis – Financial Results
- Automotive Properties Real Estate Investment Trust (APR-UN.TO) Income Statement Analysis – Financial Results
- AJ1G, Inc. (AJYG) Income Statement Analysis – Financial Results
- Shengtak New Material Co., Ltd (300881.SZ) Income Statement Analysis – Financial Results
InterCure Ltd. (INCR.TA)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.intercure.co
About InterCure Ltd.
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 355.55M | 388.68M | 219.68M | 65.04M | 8.93M | 0.00 | 0.00 | 0.00 | 1.40M | 5.65M | 8.25M | 8.47M | 12.07M | 13.23M |
| Cost of Revenue | 250.46M | 233.60M | 128.55M | 33.06M | 7.45M | 0.00 | 0.00 | 0.00 | 538.71K | 1.87M | 1.84M | 1.99M | 2.89M | 3.13M |
| Gross Profit | 105.10M | 155.08M | 91.13M | 31.98M | 1.48M | 0.00 | 0.00 | 0.00 | 862.71K | 3.78M | 6.41M | 6.47M | 9.18M | 10.10M |
| Gross Profit Ratio | 29.56% | 39.90% | 41.48% | 49.17% | 16.57% | 0.00% | 0.00% | 0.00% | 61.56% | 66.85% | 77.67% | 76.44% | 76.03% | 76.34% |
| Research & Development | 388.00K | 632.00K | 1.24M | 1.58M | 1.71M | 0.00 | 0.00 | 0.00 | 0.00 | 50.62K | 104.48K | 351.18K | 844.93K | 1.03M |
| General & Administrative | 64.30M | 91.72M | 30.73M | 17.86M | 76.36M | 9.81M | 1.12M | 1.40M | 2.02M | 3.17M | 2.88M | 4.52M | 5.16M | 8.59M |
| Selling & Marketing | 21.94M | 5.60M | 23.21M | 8.44M | 2.69M | 0.00 | 0.00 | 0.00 | 167.86K | 2.54M | 5.22M | 3.62M | 4.46M | 4.97M |
| SG&A | 86.24M | 97.32M | 53.94M | 26.30M | 79.05M | 9.81M | 1.12M | 1.40M | 2.19M | 5.71M | 8.10M | 8.14M | 9.63M | 13.56M |
| Other Expenses | 60.04M | 4.20M | 2.93M | 745.00K | 853.00K | 0.00 | 24.33K | 369.27K | 89.78K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 146.66M | 102.15M | 58.11M | 28.62M | 81.62M | 9.81M | 1.12M | 1.40M | 2.39M | 5.90M | 8.34M | 8.65M | 10.98M | 15.10M |
| Cost & Expenses | 397.12M | 335.76M | 186.65M | 61.68M | 89.06M | 9.81M | 1.12M | 1.40M | 2.92M | 7.77M | 10.19M | 10.64M | 13.87M | 18.23M |
| Interest Income | 4.55M | 844.00K | 130.00K | 21.00K | 141.00K | 0.00 | 0.00 | 0.00 | 19.52K | 0.00 | 0.00 | 3.74K | -68.51K | 3.55K |
| Interest Expense | 24.22M | 14.69M | 5.05M | 264.00K | 1.84M | 1.03M | 639.51K | 411.59K | 0.00 | 0.00 | 86.69K | 1.83M | 7.08M | 8.81M |
| Depreciation & Amortization | 13.17M | 11.70M | 7.39M | 3.25M | 23.00K | 10.00K | 4.00K | 979.00K | 870.52K | 23.36K | 142.78K | 112.08K | 224.55K | 496.72K |
| EBITDA | -23.90M | 64.50M | 37.45M | -34.53M | -21.20M | -10.12M | -1.15M | 0.00 | -1.64M | -3.77M | -1.88M | -2.09M | -1.65M | -4.60M |
| EBITDA Ratio | -6.72% | 16.59% | 17.11% | 2.78% | -237.55% | 0.00% | 0.00% | 0.00% | -116.99% | -39.08% | -22.79% | -25.10% | -13.65% | -34.76% |
| Operating Income | -41.57M | 52.80M | 28.19M | -1.45M | -80.14M | -10.62M | -3.98M | 1.20M | -2.51M | 2.67M | -1.94M | -2.17M | -1.80M | -5.00M |
| Operating Income Ratio | -11.69% | 13.58% | 12.83% | -2.23% | -897.78% | 0.00% | 0.00% | 0.00% | -179.11% | 47.28% | -23.47% | -25.67% | -14.95% | -37.82% |
| Total Other Income/Expenses | -19.72M | -6.79M | -9.45M | 92.00K | -3.15M | -2.18M | -1.28M | -938.57K | 627.79K | -1.12M | -4.68M | 45.62M | -4.96M | -7.51M |
| Income Before Tax | -61.29M | 43.84M | 18.74M | -38.31M | -3.67M | -12.80M | -5.26M | 265.42K | -1.88M | -3.79M | -6.61M | 43.44M | -6.76M | -12.52M |
| Income Before Tax Ratio | -17.24% | 11.28% | 8.53% | -58.90% | -41.10% | 0.00% | 0.00% | 0.00% | -133.98% | -67.13% | -80.08% | 512.92% | -56.01% | -94.64% |
| Income Tax Expense | 2.25M | 93.00K | 11.44M | -2.27M | -673.00K | 2.68M | 663.84K | 3.05M | -780.73K | 0.00 | 87.06K | 1.83M | 41.87K | 46.12K |
| Net Income | -61.96M | 44.82M | 7.30M | -36.04M | -3.00M | -12.80M | -5.26M | 265.42K | -1.88M | -3.79M | -6.61M | 43.44M | -6.80M | -12.56M |
| Net Income Ratio | -17.43% | 11.53% | 3.32% | -55.42% | -33.56% | 0.00% | 0.00% | 0.00% | -133.98% | -67.13% | -80.08% | 512.92% | -56.35% | -94.98% |
| EPS | -1.36 | 0.99 | 0.16 | -1.42 | -0.13 | -0.62 | -0.31 | 0.02 | -0.21 | -2.34 | -4.36 | 711.66 | -23.15 | -42.77 |
| EPS Diluted | -1.36 | 0.99 | 0.16 | -1.42 | -0.13 | -0.62 | -0.31 | 0.02 | -0.21 | -2.34 | -4.36 | 585.98 | -23.15 | -42.77 |
| Weighted Avg Shares Out | 45.56M | 45.35M | 46.92M | 25.40M | 23.30M | 20.60M | 16.78M | 12.58M | 8.85M | 1.62M | 1.51M | 380.97K | 293.74K | 293.74K |
| Weighted Avg Shares Out (Dil) | 45.57M | 45.35M | 46.92M | 25.40M | 23.30M | 20.60M | 17.11M | 12.90M | 8.85M | 1.62M | 1.51M | 462.21K | 293.74K | 293.74K |
Source: https://incomestatements.info
Category: Stock Reports